A survey of cancer physicians found 83% were not able to prescribe a preferred drug because of shortages and more than 75% said shortages required them to make major treatment changes, such as switching drugs, delaying treatment or skipping doses, University of Pennsylvania researchers reported. The research letter in the New England Journal of Medicine said shortages "compromise the delivery of standard cancer care and lead to higher costs."
Cancer doctors say drug shortages affect treatment plans
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management